Literature DB >> 16258633

Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

P A Montanheiro1, P A Montanheito, A C Penalva de Oliveira, M P Posada-Vergara, A C Milagres, C Tauil, P E Marchiori, A J S Duarte, J Casseb.   

Abstract

To evaluate the human T-cell lymphotropic virus type I (HTLV-I) proviral DNA load among asymptomatic HTLV-I-infected carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), real time PCR using TaqMan probes for the pol gene was performed in two million peripheral blood mononuclear cells (PBMC). The albumin gene was the internal genomic control and MT2 cells were used as positive control. The results are reported as copies/10,000 PBMC, and the detection limit was 10 copies. A total of 89 subjects (44 HAM/TSP and 45 healthy HTLV-I-infected carriers) followed up at the Institute of Infectious Diseases "Emilio Ribas" and in the Neurology Division of Hospital of Clínicas were studied. The asymptomatic HTLV-I-infected carriers had a median number of 271 copies (ranging from 5 to 4756 copies), whereas the HAM/TSP cases presented a median of 679 copies (5-5360 copies) in 10,000 PBMC. Thus, HAM/TSP patients presented a significantly higher HTLV-I proviral DNA load than healthy HTLV-I carriers (P = 0.005, one-way Mann-Whitney test). As observed in other persistent infections, proviral DNA load quantification may be an important tool for monotoring HTLV-I-infected subjects. However, long-term follow-up is necessary to validate this assay in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258633     DOI: 10.1590/s0100-879x2005001100011

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  23 in total

1.  Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1.

Authors:  Ana Karina Ferraz-Chaoui; Ajax Mercês Atta; Maria Luiza Sousa Atta; Bernardo Galvão-Castro; Mittermayer B Santiago
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

2.  Detection and genotyping of HPV in urine samples from Chilean women attending primary health care centers.

Authors:  Nicolás Vergara; Monserrat Balanda; Wilma Hidalgo; Héctor San Martín; Alexis Aceituno; Francisco Roldán; Tania Villalón; Melissa Hott; Gloria Espinoza; Andrea Quiero; María T Valenzuela; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2017-12-14       Impact factor: 3.402

3.  Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.

Authors:  Monserrat Balanda; Jorge Fernández; Nicolás Vergara; Constanza Campano; Loredana Arata; Héctor San Martín; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2019-06-04       Impact factor: 3.402

4.  Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.

Authors:  Claudio Fenizia; Martina Fiocchi; Kathryn Jones; Robyn Washington Parks; Michele Ceribelli; Sebastien A Chevalier; Dustin Edwards; Francis Ruscetti; Cynthia A Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

5.  Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.

Authors:  Monserrat Balanda; Andrea Quiero; Nicolás Vergara; Gloria Espinoza; Héctor San Martín; Giovanna Rojas; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2016-08-18       Impact factor: 3.402

6.  SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.

Authors:  Vanessa Adaui; Kristien Verdonck; Iván Best; Elsa González; Martín Tipismana; Jorge Arévalo; Guido Vanham; Miguel Campos; Mirko Zimic; Eduardo Gotuzzo
Journal:  J Neurovirol       Date:  2006-12       Impact factor: 2.643

7.  Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization.

Authors:  Maria Fernanda Rios Grassi; Viviana Nilla Olavarria; Ramon de Almeida Kruschewsky; Yoshihisa Yamano; Steven Jacobson; Graham P Taylor; Fabiola Martin; Bernardo Galvão-Castro
Journal:  J Clin Virol       Date:  2013-09-13       Impact factor: 3.168

8.  Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination.

Authors:  Britta Moens; Giovanni López; Vanessa Adaui; Elsa González; Lien Kerremans; Daniel Clark; Kristien Verdonck; Eduardo Gotuzzo; Guido Vanham; Olivier Cassar; Antoine Gessain; Anne-Mieke Vandamme; Sonia Van Dooren
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

9.  Prognosis Markers for Monitoring HTLV-1 Neurologic Disease.

Authors:  Gabriela Prates; Tatiane Assone; Marcelo Corral; Maíra P M Baldassin; Tatiane Mitiko; Flávia C Silva Sales; Michel E Haziot; Jerusa Smid; Luiz A M Fonseca; Fernanda de Toledo Gonçalves; Augusto C Penalva de Oliveira; Jorge Casseb
Journal:  Neurol Clin Pract       Date:  2021-04

10.  Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.

Authors:  R Brad Jones; Fabio E Leal; Aaron M Hasenkrug; Aluisio C Segurado; Douglas F Nixon; Mario A Ostrowski; Esper G Kallas
Journal:  J Negat Results Biomed       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.